Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |